Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

5-Azacytidine and Venetoclax Combination Boost Vγ9Vδ2 T Cell Effector Functions

Anne-Charlotte Le Floch, Elisabeth Wieduwild, Anne-Sophie Chretien, Florence Orlanducci, Céline Garulli, Sarah Bourass, Caroline Imbert, Aude De Gassart, Norbert Vey, Loui Madakamutil, Daniel Olive

Blood (2022) 140 (Supplement 1): 11535–11536.

https://doi.org/10.1182/blood-2022-165161

Published: 2022

Journal Articles

Targeting BTN2A1 By a Unique Activating Mab Improves Vγ9Vδ2 T Cell Cytotoxicity Against Primary Acute Lymphoblastic Blasts

Anne-Charlotte Le Floch, Caroline Imbert, Aude De Gassart, Florence Orlanducci, Aude Le Roy, Laurent Gorvel, Norbert Vey, Antoine Briantais, Nicolas Boucherit, Carla E Cano, Daniel Olive

Blood (2021) 138 (Supplement 1): 2302.

https://doi.org/10.1182/blood-2021-152577

Published: 2021

Journal Articles

Chimerized Anti-ICOS 314.8 Monoclonal Antibodies Inhibit Tumor Cells and Regulatory T Cells in Patients with Sézary Syndrome

Florent Amatore, Mathilde Barré, Florence Orlanducci, Marc Lopez, Remy Castellano, Caroline Ram-Wolff, Laurent Gorvel, Armelle Goubard, Caroline Gaudy-Marqueste, Martine Bagot, Armand Bensussan, Emmanuel Delaporte, Daniel Olive

Blood (2021) 138 (Supplement 1): 2260.

https://doi.org/10.1182/blood-2021-153345

Published: 2021

Journal Articles

ICOS Is Widely Expressed in Cutaneous T-Cell Lymphoma and Its Targeting Promotes Potent Killing of Malignant Cells

Florent Amatore, Nicolas Ortonne, Marc Lopez, Mathilde Barré, Florence Orlanducci, Remy Castellano, Saskia Ingen-Housz-Oro, Amandine De Croos, Laurent Gorvel, Armelle Goubard, Reda Bouabdallah, Jean Marc Schiano De Colella, Jean-Jacques Grob, Philippe Gaulard, Martine Bagot, Armand Bensussan, Emmanuel Delaporte, Daniel Olive

Blood (2021) 138 (Supplement 1): 790.

https://doi.org/10.1182/blood-2021-150677

Published: 2021

Journal Articles

Anti-BTN3A 20.1 Agonist Monoclonal Antibody Enhances Autologous Vγ9Vδ2 T Cells Cytotoxicity Against Primary Acute Myeloid Blasts

Anne-Charlotte Le Floch, MBBS, MSc, Florence Orlanducci, Antoine Briantais, Aude Le Roy, Anne-Sophie Chretien, Norbert Vey, MD PhD, Daniel Olive, MD PhD

Blood (2019) 134 (Supplement_1): 5153.

https://doi.org/10.1182/blood-2019-125541

Published: 2019

Journal Articles

The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells

Julie Gertner-Dardenne, Cyril Fauriat, Florence Orlanducci, Marie-Laure Thibult, Sonia Pastor, Jude Fitzgibbon, Reda Bouabdallah, Luc Xerri, Daniel Olive

Blood (2013) 122 (6): 922–931.

https://doi.org/10.1182/blood-2012-11-464685

Published: 2013

Includes: Supplemental data

Journal Articles

Defective Triggering of NK Cells Results in Primary CLL Cells Resistance to Cytotoxicity,

Caroline Veuillen, PhD, Jerome Rey, MD, Rémy Castellano, PhD, Florence Orlanducci, Françoise Mallet, Sylvaine Just-Landi, Diane Coso, MD, Vadim Ivanov, MD, PhD, Xavier Carcopino, MD, Reda Bouabdallah, MD, Yves Collette, PhD, Cyril Fauriat, PhD, Daniel Olive, MD, PhD, Thérèse Aurran, MD

Blood (2011) 118 (21): 3876.

https://doi.org/10.1182/blood.V118.21.3876.3876

Published: 2011

Journal Articles

Anti-Leukemic Effect of IMiDs® in AML Involves the Direct Cytotoxicity Effects in Addition to a Biased NK Activation,

Aude Le Roy, Norbert Vey, MD, Cyril Fauriat, Florence Orlanducci, Scott Bateman, Daniel Olive, MD, PhD

Blood (2011) 118 (21): 3224.

https://doi.org/10.1182/blood.V118.21.3224.3224

Published: 2011

Journal Articles

Natural Killer Cells Recovery After Consolidation Chemotherapy in Elderly Patients with Acute Myeloid Leukemia (AML)

Jerome Rey, MD, Nicolas Anfossi, PhD, Pascale Andre, PhD, Jean-Marie Boher, Florence Orlanducci, Violette Breso, Valentine Perri, Thomas Prebet, MD, PhD, Aude Charbonnier, MD, PhD, Eloïse Perrot, Francois Romagne, PhD, Norbert Vey, MD, Daniel Olive, MD, PhD

Blood (2011) 118 (21): 2189.

https://doi.org/10.1182/blood.V118.21.2189.2189

Published: 2011

Journal Articles

Long Lasting Alteration of Natural Killer Cells Post-Chemotherapy in Elderly Patients with Acute Myeloid Leukemia (AML).

Daniel Olive, MD, PhD, Nicolas Anfossi, Pascale Andre, PhD, Jerome Rey, Florence Orlanducci, Violette Breso, Valentine Peri, Thomas Prébet, MD, Aude Charbonnier, MD, PhD, Eloise Perrot, Francois Romagne, PhD, Norbert Vey

Blood (2009) 114 (22): 1653.

https://doi.org/10.1182/blood.V114.22.1653.1653

Published: 2009

NARROW

5-Azacytidine and Venetoclax Combination Boost Vγ9Vδ2 T Cell Effector Functions

Targeting BTN2A1 By a Unique Activating Mab Improves Vγ9Vδ2 T Cell Cytotoxicity Against Primary Acute Lymphoblastic Blasts

Chimerized Anti-ICOS 314.8 Monoclonal Antibodies Inhibit Tumor Cells and Regulatory T Cells in Patients with Sézary Syndrome

ICOS Is Widely Expressed in Cutaneous T-Cell Lymphoma and Its Targeting Promotes Potent Killing of Malignant Cells

Anti-BTN3A 20.1 Agonist Monoclonal Antibody Enhances Autologous Vγ9Vδ2 T Cells Cytotoxicity Against Primary Acute Myeloid Blasts

The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells

Defective Triggering of NK Cells Results in Primary CLL Cells Resistance to Cytotoxicity,

Anti-Leukemic Effect of IMiDs® in AML Involves the Direct Cytotoxicity Effects in Addition to a Biased NK Activation,

Natural Killer Cells Recovery After Consolidation Chemotherapy in Elderly Patients with Acute Myeloid Leukemia (AML)

Long Lasting Alteration of Natural Killer Cells Post-Chemotherapy in Elderly Patients with Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only